SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827871-23-000021
Filing Date
2023-08-08
Accepted
2023-08-08 16:10:44
Documents
81
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q egrx-20230630.htm   iXBRL 10-Q 1352073
2 EX-31.1 exhibit311q22023.htm EX-31.1 8380
3 EX-31.2 exhibit312q22023.htm EX-31.2 8339
4 EX-32 exhibit321q22023.htm EX-32 8937
  Complete submission text file 0000827871-23-000021.txt   7605367

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20230630.xsd EX-101.SCH 53147
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20230630_cal.xml EX-101.CAL 104038
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20230630_def.xml EX-101.DEF 244497
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20230630_lab.xml EX-101.LAB 673703
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20230630_pre.xml EX-101.PRE 430623
75 EXTRACTED XBRL INSTANCE DOCUMENT egrx-20230630_htm.xml XML 1175174
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36306 | Film No.: 231151387
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences